RDHL

Redhill Biopharma
RDHL

Overview Fund Activity

9 hedge funds and large institutions have $15.5M invested in Redhill Biopharma in 2014 Q1 according to their latest regulatory filings, with 8 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

Holders
9
Holders Change
+8
Holders Change %
+800%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
O
1
OrbiMed
New York
$8.9M
2
BC
2
Broadfin Capital
New York
$3.71M
3
SFM
3
Sphera Funds Management
Israel
$2.43M
4
Wells Fargo
4
Wells Fargo
California
$42K
5
TRCT
5
Tower Research Capital (TRC)
New York
$11K

Top Sellers

No sellers this quarter
Name Market Value Shares Shares
Change 		Shares
Change %
O
1
OrbiMed
New York
$8.9M 631,580 +631,580 New
BC
2
Broadfin Capital
New York
$3.71M 263,160 +263,160 New
SFM
3
Sphera Funds Management
Israel
$2.43M 1,714,880 +1,714,880 New
Goldman Sachs
4
Goldman Sachs
New York
$409K 29,000 – –
Wells Fargo
5
Wells Fargo
California
$42K 3,000 +3,000 New
TRCT
6
Tower Research Capital (TRC)
New York
$11K 795 +795 New
U
7
UBS
Switzerland
$4K 300 +300 New
Citigroup
8
Citigroup
New York
$1K 100 +100 New
Morgan Stanley
9
Morgan Stanley
New York
$0 2 +2 New